(Q40557468)

21 September 2017

The biological effects of five feline IFN-alpha subtypes (English)

1 reference

21 September 2017

Susan L Baldwin

1

1 reference

21 September 2017

Tim D Powell

2

1 reference

21 September 2017

Karen S Sellins

3

1 reference

21 September 2017

Steven V Radecki

4

1 reference

21 September 2017

J John Cohen

5

1 reference

21 September 2017

Michael J Milhausen

6

1 reference

21 September 2017

1 June 2004

1 reference

Veterinary Immunology and Immunopathology

21 September 2017

1 reference

21 September 2017

99

1 reference

21 September 2017

3-4

1 reference

21 September 2017

153-167

1 reference

The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

A Study of Feline Upper Respiratory Tract Disease with Reference to Prevalence and Risk Factors for Infection with Feline Calicivirus and Feline Herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Sites of persistence of feline calicivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Efficacy of an inactivated feline calicivirus (FCV) vaccine against challenge with United Kingdom field strains and its interaction with the FCV carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Induction of Mx-related protein in cat peripheral blood mononuclear cells after administration of recombinant human interferon hybrid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Specific antiviral activities of the human alpha interferons are determined at the level of receptor (IFNAR) structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Molecular cloning of feline interferon cDNA by direct expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Interaction of a combined feline viral rhinotracheitis-feline calicivirus vaccine and the FVR carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

A species of human alpha interferon that lacks the ability to boost human natural killer activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Immunization of dogs and cats with a DNA vaccine against rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Feline Melanoma: A Comparative Study of Ocular, Oral, and Dermal Neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Antiviral actions of interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Measurement of antiviral activity induced by interferons alpha, beta, and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Antiviral activities of hybrids of two major human leukocyte interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Cloning, expression, purification, and biological activity of five feline type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2004.01.012

1 reference

21 September 2017

1 reference